Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Aesthetics Biomedical Awarded Several Top Honors

Dedication to Innovation Drives Multifaceted Recognition for the Company Behind SoME® Skincare and Vivace® Microneedle RF


News provided by

Aesthetics Biomedical

Jul 03, 2020, 12:00 ET

Share this article

Share toX

Share this article

Share toX

Aesthetics Biomedical
Aesthetics Biomedical

PHOENIX, July 3, 2020 /PRNewswire-PRWeb/ -- Aesthetics Biomedical (ABM), a leading aesthetics product development corporation, is proud to earn outstanding recognition and multiple awards for not only the products and treatments developed, but also the dedicated team behind the brands under the ABM portfolio, SoME® Skincare and Vivace® Microneedle RF. All the brands built by ABM have received several honors already for 2020, each of which comes from different voting measures and audiences – physicians, aesthetic industry peers, top beauty industry experts, and the media.

"Striving to innovate and enrich the patient experience are principles that Aesthetics Biomedical was founded on. Earning such coveted awards and recognition from our peers, patients, top beauty press and experts, is the ultimate testimonial to our portfolio of treatments and products. Our mission at ABM propels us to revolutionize the aesthetic industry for both patients and providers alike." Says MaryAnn Guerra, Aesthetics Biomedical President and CEO. (and recipient of the Aesthetic Everything Top Women In Aesthetics CEO Award!)

Striving to innovate and enrich the patient experience are principles that Aesthetics Biomedical was founded on. Earning such coveted awards and recognition from our peers, patients, top beauty press and experts, is the ultimate testimonial to our portfolio of treatments and products.

Post this

Having launched to physicians less than a year ago, SoME® Skincare has taken the market by storm with physicians and the media praising the product's unrivaled results and approach to personalized skincare. Named by NEWBEAUTY Magazine as the Top Innovation in the 2020 Beauty Authority Awards and winning the title of Top Medical Skincare Line from Aesthetic Everything, a popular resource within the industry, reflects the quality and innovation underpinning SoME®.

SoME® Skincare That's All You is the only patented, clinically proven, personalized skincare for at-home use. When combined with Platelet Rich Plasma (PRP), SoME® uses the body's own regenerative properties to stimulate natural collagen and elastin for visibly renewed firmness and luminosity, while reducing the appearance of fine lines, discoloration and puffiness around the eyes. The cosmetic serum was formulated and rigorously tested by Aesthetics Biomedical to ensure that when combined with an individual's PRP, as recommended by your physician, the platelets are preserved for optimal effect upon use. Preservation of the platelet components is key as this patented discovery allows the product to remain efficacious over the course of at least three months, an unprecedented scientific finding that is disrupting the aesthetic beauty industry.

Vivace® RF Microneedle, which has quickly become a favorite among consumers and celebrities, accumulated several titles from the 2020 Aesthetic Everything Awards, including: Top Aesthetic Company and Product; and Top Aesthetic RF & Skincare Company. Continuing with the industry voted recognition – Vivace® also earned the My Face My Body Award this year. An ultimate endorsement of the leading RF Microneedling treatment came from this year's RealSelf "Most Worth It" Awards, where Vivace® was the only microneedling treatment to be voted onto the prestigious list by actual patients benefiting from the treatment.

Vivace® is a minimally invasive, FDA-cleared, radiofrequency microneedling treatment that stimulates the natural production of collagen and has been shown by physicians to be effective in alleviating facial wrinkles, fine lines, and tightening and toning the face and neck. Uniquely designed for an unparalleled patient experience and comfort levels, only Vivace® boasts a precision robotic motor that creates a virtually pain-free experience compared to any other device in physicians' offices.

Aesthetics Biomedical is also home to the winner of the Aesthetic Everything Top Chief Marketing Officer Award, Sheldon Larson: "Our unrivaled microneedling treatment and first-of-its-kind, patented personalized skincare have grown to be a favorite among celebrities and media alike, take the NewBeauty Award for example, which named SoME® Skincare as the year's Most Innovative, an impressive accolade bestowed after having been tested, by top beauty experts, along with 9,000 other cosmetic products" Larson continues, "It truly speaks volumes about a product when people from all different regions, backgrounds, and industries also praise the skincare products and treatments. Such is the case with the RealSelf 'Most Worth It' Award which was earned 100% by consumer votes, recognizing Vivace Experience® for its value. 'I'm also proud to note that Vivace Experience® was the only microneedling treatment to earn this year's coveted recognition."

About Aesthetics Biomedical
Aesthetics Biomedical, Inc., headquartered in Phoenix, Ariz., is committed to the development and distribution of novel aesthetic devices, products, and services in the global market. Aesthetics Biomedical's innovation center is a leader in breakthrough technologies and combination therapies for its clients, physician network and the aesthetic arena, creating novel patient treatment experiences that benefit from ongoing research, approved clinical indications for use, as well as a personalized approach designed for consumer benefit. Visit AestheticsBiomedical.com

CONTACTS:
Marketing Contact: Sheldon Larson, Chief Marketing Officer ([email protected])
Press Contact: Courtney Frappier, Senior PR Manager ([email protected])

SOURCE Aesthetics Biomedical

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.